logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Chia-Jui Yen

National Cheng Kung University Hospital
H指数:36
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

作者更正：替雷利珠单抗或安慰剂联合化疗作为晚期鼻咽癌的一线治疗：一项多中心随机III期试验

Nature Medicine
IF50
2026-10-270
PRE
Hai-Qiang Mai; Qiu-Yan Chen; Dongping Chen; Chaosu Hu; Kunyu Yang; Jiyu Wen; Jingao Li; Ying-Rui Shi; Feng Jin; Ruilian Xu; Jianji Pan; Shenhong Qu; Ping Li; Chunhong Hu; Yi-Chun Liu; Yi Jiang; Xia He; Hung-Ming Wang; Wan-Teck Lim; Wangjun Liao; Xiaohui He; Xiaozhong Chen; Zhigang Liu; Xianglin Yuan; Qi Li; Xiaoyan Lin; Shanghua Jing; Yanju Chen; Yin Lu; Ching-Yun Hsieh; Muh-Hwa Yang; Chia-Jui Yen; Jens Samol; Hui Feng; Sheng Yao; Patricia Keegan; Rui-Hua Xu
Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial

新型口服抗血管生成拟态药物CVM-1118在晚期分化良好的神经内分泌肿瘤中的疗效与安全性：一项IIa期临床试验

British Journal of Cancer
IF6.8
2026-07-020
OA
Chia-Jui Yen; Ming-Huang Chen; Yen-Yang Chen; Li-Yuan Bai; Jen-Shi Chen; Jason Chia-Hsun Hsieh; Yu-Hsuan Shih; I-Chen Wu; Yen-Ling Chen; Chun-Man Chen; Ting-Yu Chao; Yi-Wen Chu; Du-Shieng Chien
Nucleotide excision repair and poly(ADP-ribose) polymerase 1 cooperate in hepatitis B virus cccDNA synthesis, offering a potential viral therapeutic target

核苷酸切除修复和聚(ADP-核糖)聚合酶1在乙型肝炎病毒cccDNA合成中协同作用，提供了一个潜在的抗病毒治疗靶点。

JHEP Reports
IF7.5
2026-02-280
OAAI
Hsu-Chin Hung; Hung-Wen Tsai; Yung-Tsung Li; Wen-Chun Liu; Kuang-Hsiung Cheng; Chia-Jui Yen; Yun-Ping Lee; Yuan-Hsin Fang; Cheng-Hsiang Chuang; Hui-Lin Wu; Ting-Tsung Chang; Wenya Huang
A phase I/II study using cabozantinib and lanreotide as treatments for advanced GEP-NETs for which molecular targeted therapy or chemotherapy have failed (SCALET): TCOG T2221 study

I/II期研究使用卡博替尼和兰瑞肽治疗分子靶向治疗或化疗失败的晚期GEP-NETs（SCALET）：TCOG T2221研究

ESMO Open
IF8.3
2026-01-010
OA
Hui‐Jen Tsai; Ming‐Huang Chen; Chin‐Fu Hsiao; L.-Y. Bai; Y.-Y. Chen; W.-C. Chou; Yung‐Yeh Su; M.-S. Dai; Y.-H. Liang; Y.-S. Shan; Chia‐Jui Yen; Tsung‐Hao Liu; J.-S. Chen; C.-Y. Yang; Chih‐Chieh Yen; J.-S. Chen; H.-C. Hsu; Yu‐Li Su; Chia‐Hsun Hsieh; Li‐Tzong Chen
Enhanced Catalytic Cycle of Glucose Oxidation and Reactive Species with ROS and RHS Generation Mediated by Galvanic Engineering of Dual Atomic Sites on Covalent Organic Frameworks Demonstrating Synergistic Bimetal Tumor Treatment

通过共价有机骨架上双原子位点的电化学工程介导的葡萄糖氧化和活性物种增强催化循环，并产生ROS和RHS，展示了协同双金属肿瘤治疗的机制。

Advanced Science
IF14.1
2025-05-280
OAAI
Wei-Chung Pan; Cheng-Hung Luo; Wen-Ling Lin; Liu-Chun Wang; Divinah Manoharan; Po-Ya Chang; Hwo-Shuenn Sheu; Chen-Hao Yeh; Chia-Jui Yen; Chen-Sheng Yeh
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT as fi rst-line (1L) treatment for recurrent or metastatic nasopharyngeal cancer (NPC): 3-year follow-up from the RATIONALE-309 study

替雷利珠单抗（TIS）联合化疗（CT）对比安慰剂（PBO）联合化疗（CT）作为复发性或转移性鼻咽癌（NPC）的一线（1L）治疗方案：RATIONALE-309研究的3年随访结果

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Fang, W. F.; Pan, J.; Wang, H.; Qu, S.; Chen, N.; Chen, X.; Sun, Y.; He, X.; Hu, C.; Lin, L.; Yen, C. J.; Wu, Y.; Yuan, S.; Chen, C.; Yang, Y.; Lean, S.; Zhang, L.
Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen
BMC CANCER
IF3.4
2024-10-050
OAAI
Yang, Muh-Hwa; Chen, Tien-Hua; Wang, Hung-Ming; Hsieh, Jason Chia-Hsun; Huang, Huai-Cheng; Hsieh, Meng-Che; Yen, Chia-Jui; Wu, Shang-Yin; Hua, Chun-Hung; Lien, Ming-Yu; Chang, Yi-Fang; Wang, Hui-Ching; Chien, Chih-Yen; Huang, Tai-Lin; Lu, Hsueh-Ju; Lin, Jin-Ching; Wang, Chen-Chi; Liu, Yi-Chun; Chen, Jo-Pai; Lu, Wei-Chen; Yiu, Ching-Yi; Lin, Chien-Liang; Lou, Pei-Jen; Chu, Pen-Yuan
CVM-005: Phase IIa study of CVM-1118, a novel oral antivasculogenic mimicry (VM) agent, in advanced neuroendocrine tumors (NET) after progression on prior therapy

CVM-005：CVM-1118的一项IIa期研究，CVM-1118是一种新型的口服抗血管生成拟态（VM）药物，用于先前治疗进展后的晚期神经内分泌肿瘤（NET）患者。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Yen, C. J.; Chen, M-H.; Chen, Y. Y.; Bai, L-Y.; Chen, J-S.; Hsieh, J. C-H.; Shih, Y-H.; Wu, I-C.; Chen, Y-L.; Chen, C-M.; Chao, T-Y.; Chu, Y-W.; Chien, D-S.
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries

亚太国家一线阿特珠单抗联合贝伐单抗治疗肝细胞癌后系统治疗的真实世界研究

LIVER CANCER
IF9.1
2024-08-200
OAAI
Lee, Choong-kun; Yoo, Changhoon; Hong, Jung Yong; Park, Se Jun; Kim, Jin Won; Tai, David Wai Meng; Kim, Hyeyeong; Korphaisarn, Krittiya; Tanasanvimon, Suebpong; Chen, San-Chi; Kim, Ju Won; Kim, Ilhwan; Kim, Moonho; Choo, Joan; Oh, Sang-Bo; Chen, Ching-Tso; Bae, Woo Kyun; Kim, Hongsik; Huh, Seok Jae; Yen, Chia-Jui; Park, Sejung; Lee, Dong Ki; Chan, Landon Long; Kang, Beodeul; Kang, Minsu; Sundar, Raghav; Choi, Hye Jin; Chan, Stephen Lam; Chon, Hong Jae; Lee, Myung-Ah
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan

胰腺癌同源重组基因的种系突变和临床结果: 台湾的多中心研究

JOURNAL OF BIOMEDICAL SCIENCE
IF12.1
2024-02-134
OAAI
Cheng, Siao Muk; Su, Yung-Yeh; Chiang, Nai-Jung; Wang, Chih-Jung; Chao, Ying-Jui; Huang, Chien-Jui; Tsai, Hui-Jen; Chen, Shang-Hung; Chang, Chi-Yen; Tsai, Chia-Rung; Li, Yi-Jie; Yen, Chia-Jui; Chuang, Shih-Chang; Chang, Jeffrey Shu-Ming; Shan, Yan-Shen; Hwang, Daw-Yang; Chen, Li-Tzong

研究方向

暂未获取到该数据
Y
Yan‐Shen Shan
H 指数:41论文数:374被引数:7,507
N
Nai‐Jung Chiang
H 指数:22论文数:150被引数:1,492
L
Li‐Tzong Chen
H 指数:55论文数:538被引数:1.7万
Y
Yung‐Yeh Su
H 指数:13论文数:70被引数:413
L
Li‐Yuan Bai
H 指数:26论文数:230被引数:4,141
A
Ann‐Lii Cheng
H 指数:102论文数:1,290被引数:7.5万
C
Chih‐Chieh Yen
H 指数:4论文数:13被引数:66
Y
Ying‐Jui Chao
H 指数:16论文数:73被引数:1,038
W
Wenya Huang
H 指数:33论文数:108被引数:3,379
H
Hui‐Jen Tsai
H 指数:18论文数:100被引数:879